The absence of TREM2 enhances the anti-PD-1-mediated immunotherapy in CRC animal models, with a study revealing that MC38 tumor growth was significantly inhibited in Trem2–/– mice compared to that in wild-type mice [20]. This evidence concerns the gene TREM2 and colorectal carcinoma.